November 7, 2018
Akers Biosciences (NASDAQ:AKER) (AIM:AKR.L) a developer of rapid health information technologies, announces that the Board of Directors has initiated a...
September 7, 2017
Akers Biosciences announced the appointment of a new vice president for sales and distribution of the company.
August 8, 2017
Akers Biosciences announced a set of changes to its board of directors.
April 10, 2017
Akers Biosciences is marketing its rapid test for heparin-induced thrombocytopenia to hospitals in Puerto Rico.
March 31, 2017
Akers Biosciences (NASDAQ:AKER) plans to raise close to $2 million through a private placement with Joseph Gunnar & Co., LLC.